Ticker
DNTHCompany Name
DIANTHUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 326.08M | $ 1.33M | 0.41% |
3/31/2025 | $ 348.58M | $ 1.4M | 0.4% |
12/31/2024 | $ 374.01M | $ 1.49M | 0.4% |
9/30/2024 | $ 354.25M | $ 311K | 0.09% |
6/30/2024 | $ 368.96M | $ 407K | 0.11% |
3/31/2024 | $ 382.46M | $ 497K | 0.13% |
12/31/2023 | $ 179.41M | $ 585K | 0.33% |
9/30/2023 | $ 192.46M | $ 670K | 0.35% |
6/30/2023 | $ 78.64M | $ 0 | 0% |
3/31/2023 | $ 83.44M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for DIANTHUS THERAPEUTICS INC is calculated as follows: Debt [ $ 0 ] / Assets [ $ 174.64M ]
(=) Debt to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |